Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus

International Journal of Dermatology

Volumn 37, Issue 2, 1998, Pages 140-142

  Tausch, Irene ^a,g   Decroix, Jacques ^a   Gwiezdzinski, Zenon ^b   Urbanowski, Stawomir ^c   Baran, Eugeniusz ^d   Ziarkiewicz, Marek ^e   Levy, Gary ^f   Palacio, Amalia ^f  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Bioskin Institute for Dermatological Research   (Germany)

^c Dermatology Clinic   (Belgium)

^d Klinika Dermatologiczna Medical University of Warsaw   (Poland)

^e Dermatology Clinic   (South Africa)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g Bioskin Institute for Dermatological Research and Development GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; TERBINAFINE;

ANTIFUNGAL ACTIVITY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG POTENCY; DRUG SAFETY; DRUG SPECIFICITY; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TINEA PEDIS; TREATMENT PLANNING;

ANTIFUNGAL AGENTS; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; ITRACONAZOLE; NAPHTHALENES; TINEA; TINEA PEDIS; TREATMENT OUTCOME;

EID: 0031949493     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1998.00400.x     Document Type: Article

References (9)

1. Heykants J, Michiels M, Meuldermans W, et al. The pharmacokinetics of itraconazole in animals and man: an overview. In: Fromtling RA, ed. Recent Trends in the Discovery, Development and Evaluation of Atttiftingal Agents. Barcelona, Spain: JR Prous Science Publishers, 1987: 113-249.
2. Cauwenbergh G, Degreef H, Heykants J, et al. Pharmacokinetic profile of orally administered itraconazole in human skin. ] Am Acad Dennatol 1988; 18: 263-169.
3. De Doncker P, Cauwenbergh G. Management of fungal skin infections with 15 days itraconazole treatment: a worldwide review. Br ] Clin Pract 1990; 44: 118-122.
4. Villars W, Jones TC. Special featuresof the clinical use of oral terbinafine in the treatment of fungal diseases. Er J Dennatol 1992; 126(Suppl. 39): 61-69.
5. Roseeuw D, Willemsen M, T Knit R, et al. Itraconazole in the treatment of superficial mycoses - a double-blind study vs. placebo. Clin Exp Dennatol 1990; 15: 101-104.
6. Cauwenbergh G, de Doncker P, Stoops K, et al. Itraconazole in the treatment of human mycoses: review of three years of clinical experience. Rev Infect Dis 1987; 9: 146-152.
7. Decroix J. Tinea pedis (moccasin-type) treated with itraconazole. Int J Dennatol 1995; 34: 122-124.
8. Arenas R, Dominguez-Cherit J. Open randomized comparison of itraconazole versus terbinafine in onychomycosis. Int J Dennatol 1995; 34: 138-143.
9. De Beule K, Lubin G, Cauwenbergh G. Safety aspects of itraconazole therapy in vaginal candidosis, dermatomycosis and onychomycosis: a review. Ciirr Ther Res 1991; 49: 814-812.